Molecular Chaperones in Cancer and Protein Quality Control Frontiers in Immunomodulation and Cancer Therapy (2nd edition)

Inicio | Eventos | Seminarios Distinguidos

En los CNIO Seminars se invita a un científico o científica de gran prestigio internacional a dar un seminario e interactuar con los investigadores del CNIO. Hay varios a lo largo del año, y son abiertos al público. Los conferenciantes pertenecen a una amplia diversidad de áreas, incluyendo literatura o tecnología. El objetivo es crear un entorno estimulante que despierte la mente y ayude a generar ideas.

Descargar poster en PDF

Seminarios Distinguidos 12/04/2024
Ailong Ke
New Frontiers in CRISPR-Cas Biology – RNA-guided Proteases and Ancestorial Cas9s in Transposons
Seminarios Distinguidos 22/03/2024
Andrés Hidalgo
Multidimensional neutrophils
Seminarios Distinguidos 15/03/2024
Joseph Schlessinger
Cell Signaling By Receptor Tyrosine Kinases; From Basic Principles To Cancer Therapies
Seminarios Distinguidos 08/03/2024
Lindsay Hinck
Consequences of Physiological DNA Damage in the Breast and Uterus
Seminarios Distinguidos 23/02/2024
Sjors Scheres
Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids
Seminarios Distinguidos 16/02/2024
Mariam Jamal-Hanjani
Insights into lung cancer evolution and metastasis in TRACERx and PEACE
Seminarios Distinguidos 09/02/2024
Cristina Mayor
Targeted protein degradation: drug discovery opportunities & overcoming resistance mechanisms in cancer
Seminarios Distinguidos 15/12/2023
Victoria Sanz-Moreno
Finding vulnerabilities in metastatic cancer cells
Seminarios Distinguidos 01/12/2023
Stefan Knapp
Targeting strategies for the development of highly selective allosteric and orthosteric kinase inhibitors
Seminarios Distinguidos 17/11/2023
Joseph Takahashi
Role of Circadian Clocks in Healthspan and Lifespan in Mice
Seminarios Distinguidos 03/11/2023
Walid Khaled
Tumour Initiation Through Aberrant Differentiation: Lessons from Single Cell Genomics
Seminarios Distinguidos 27/10/2023
Marta María Alonso Roldán
Locking TIM3 as a therapeutic strategy for pediatric diffuse midline Glioma

Subir